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A 41-year-oldmanwith an unremarkable medical history presented with a painful knee after a sports injury. He was diagnosed with
a medial meniscal tear. Symptoms did not abate after 6 months of physical therapy, and he underwent arthroscopic partial medial
meniscectomy. A week after beginning physical therapy he experienced a knee effusion, decreased ROM, and inability to flex his
quadriceps. His knee was aspirated. Blood tests were ordered and his complete blood count, liver functions tests, and INR/PTT
were normal. The patient had recurrent effusions requiring three additional joint aspirations. Ten weeks after the initial surgery,
the patient underwent a second arthroscopy, during which a hematoma was removed and a synovectomy performed. The patient
continued bleeding from the incisions after portals were sutured, and he was admitted to the hospital. A hematologist was consulted
and comprehensive platelet aggregation testing revealed previously undiagnosed Glanzmann’s thrombasthenia. The patient began
treatment with platelet infusions and desmopressin and progressed to a full recovery. Clinical suspicion for surgical patients with
unusual repetitive postoperative bleeding should include previously undetected rare bleeding disorders even in adults.
1. Introduction
Minor hemarthrosis (bleeding in the joint space) and pain
after arthroscopic knee surgery are not uncommon and
are usually self-limiting as healing progresses. Occasionally,
various events such as failure of the surgical repair, infec-
tion, or new traumatic injury, or unrecognized hyperten-
sion, use of anticoagulation medications, or liver disease
affecting synthesis of clotting factors may result in more
serious and repetitive hemarthrosis. Typically, however, the
surgeon does not suspect rare clotting disorders in adults
with normal results of blood tests as such inherited or
acquired disorders are usually detected early in life. In this
report, we describe a case of postoperative hemarthrosis
after arthroscopic meniscectomy in an ostensibly healthy
adult man who was later diagnosed with Glanzmann’s
thrombasthenia.
2. Case Presentation
A 41-year-old man with an unremarkable medical history
presented to the clinic with right knee pain, severity 3/10,
piercing and sharp in quality, which occurred after recre-
ational sports activity. He was diagnosed with a medial
meniscal tear confirmed by MRI. Six months of physical
therapy did not relieve the symptoms. The patient under-
went diagnostic arthroscopy, partial medial meniscectomy,
chondroplasty of the trochlea, and partial synovectomy
without intraoperative complication (bleedingwas controlled
by tourniquet). He started a home exercise program and
formal strengthening therapy began on postoperative day 10.
Then, in the absence of any particular traumatic event, he
experienced a knee effusion, decreased range of motion, and
inability to flex his quadriceps muscle on postoperative day
17.
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Upon physical exam in the clinic, mild effusion of the
right knee was noted with no ecchymosis, and laxity tests and
meniscal examswere negative. Range ofmotionwas 2 degrees
of extension and 110 degrees of flexion. Knee aspiration
was done with 62mL of serosanguinous fluid withdrawn.
The patient was taking aspirin and told to discontinue its
use. He was instructed to stop physical therapy, rest his
knee, use ice for 20 minutes 3-4 times per day, and wear
a compression wrap until his next office visit in 2 weeks.
Subsequent blood test results showed normal complete blood
count, liver function tests, and INR/PTT.
Within the next several weeks, the patient had recurrent
effusions with related symptoms requiring three additional
joint aspirations. Ten weeks after the initial surgery, the
patient underwent a second arthroscopy, during which a
hematoma was removed and a synovectomy performed. The
procedure was routine with no intraoperative complications.
However, after the procedure the patient continued bleeding
from the sutured incisions and was admitted to the hospital
for observation. A hematologist was consulted. The patient
denied previous bleeding problems. Platelet aggregation tests
revealed decreased platelet aggregation and secretion with
arachidonic acid, collagen, adenosine diphosphate (ADP),
and thrombin. In contrast, platelet aggregationwas normal in
the presence of ristocetin. These results were consistent with
the diagnosis of Glanzmann’s thrombasthenia.
After the definitive diagnosis was made, the patient
began treatment with platelet infusions and desmopressin
and progressed to a full recovery.
3. Discussion
Glanzmann’s thrombasthenia, first described in 1918 as a
hereditary hemorrhagic thrombasthenia, is a rare autosomal
recessive bleeding disorder with an estimated incidence of
1 in 1,000,000 [1–3]. It is characterized by normal platelet
count but lack of normal platelet aggregation [3].The platelet
function disorder is caused by qualitative and/or quantitative
defects in the platelet glycoprotein IIb/IIIa complex (an
integrin coded by the ITGA2B and ITGB3 genes and which
by binding fibrinogen and other adhesive proteins joins
platelets together in aggregate) [4]. Typical symptoms, which
may be constant problems in fully expressed cases, include
purpura, epistaxis, gingival hemorrhage, menorrhagia, and
prolonged bleeding after minor injuries [1]. Logically, exces-
sive bleeding during or after surgery would be expected. It
is not associated with early mortality except in cases where
excessive bleeding would be expected as with intracranial
hemorrhage or visceral hematoma. Diagnosis occurs at an
early age (usually before the age of 5 years in a cohort of
113 patients as discussed by George et al. [1]), especially if a
family member has been previously diagnosed. Glanzmann’s
thrombasthenia is a lifelong condition for which there is no
cure. Symptomsmay beminimized by avoiding use of aspirin
or other nonsteroidal anti-inflammatorymedications, such as
ibuprofen and naproxen [3].
Laboratory tests are necessary to diagnose Glanzmann’s
thrombasthenia. However, routine blood tests such as
complete blood count, liver function tests, and INR/PTT will
not detect this disorder (platelet count and morphology are
normal). The most widely used critical test for Glanzmann’s
thrombasthenia involves platelet aggregation challenges in
which various physiologic agonists are mixed with platelets
to induce clumping. Decreased platelet aggregation will
occur after mixing with arachidonic acid, collagen, ADP, and
thrombin; however, aggregation will occur in the presence
of the antibiotic ristocetin, and this finding is the definitive
diagnosis of Glanzmann’s thrombasthenia [3, 5]. Recently,
other tests and automated processes are becoming available
such as direct analysis for the presence of glycoprotein
IIb/IIIa and evaluation of whole blood samples with the PFA-
100 impedance analyzer [3, 5, 6].
In general, hemarthrosis associated with Glanzmann’s
thrombasthenia is apparently very rare despite the com-
mon symptoms noted above. George et al. reported that
hemarthrosis occurred in only 5 of 177 patients (3%) [1].
Only one of these had knee involvement. Urakawa et al.
described a case of knee hemarthrosis in an 8-year-old
boy after a sports-related injury. In the workup, he was
diagnosed with Glanzmann’s thrombasthenia [7].The patient
had a history of prolonged bleeding time after minor injuries
and prolonged purpura. There was no family history, and
previous workups did not identify the cause of the problems
as being Glanzmann’s thrombasthenia. Several reports in
the literature describe perioperative management of patients
with known Glanzmann’s thrombasthenia [8–10]. Although
cases similar to ours have been presented in which there
were postoperative hemarthrosis complications in patients
with previously unknown hemophilia or low factor XIII
activity [11], we are unaware of previously reported cases of
hemarthrosis after knee arthroscopy in a physically active
adult man who had no knowledge of having Glanzmann’s
thrombasthenia.
We note that, rarely, Glanzmann’s thrombasthenia may
present as an acquired autoimmune disorder of platelet
function, with rapid onset of bleeding events characterized by
prolonged bleeding times but with normal platelet count and
normal platelet glycoprotein expression [12].This is caused by
an antibody with specificity for platelet glycoprotein IIb/IIIa.
Our patient had no history of immune thrombocytopenia or
related conditions and thus acquired Glanzmann’s thrombas-
thenia was considered highly unlikely.
4. Conclusion
Although counterintuitive in a physically active adult, clinical
suspicion should include previously undiagnosed rare bleed-
ing disorders if there is unusual and unexplained postopera-
tive bleeding after knee arthroscopy.Once that line of thought
is established, the actual definitive diagnosis of Glanzmann’s
thrombasthenia in particular can be readily made with the
appropriate laboratory test.
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